[Federal Register Volume 86, Number 105 (Thursday, June 3, 2021)]
[Notices]
[Page 29741]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11630]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-04-2021]


Foreign-Trade Zone (FTZ) 22--Chicago, Illinois; Authorization of 
Production Activity, AbbVie, Inc. (Pharmaceutical Products), North 
Chicago and Lake County, Illinois

    On January 27, 2021, AbbVie, Inc., submitted a notification of 
proposed production activity to the FTZ Board for its facilities within 
Subzone 22S, in North Chicago and Lake County, Illinois.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (86 FR 7989, February 3, 2021). On May 
27, 2021, the applicant was notified of the FTZ Board's decision that 
no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: May 27, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-11630 Filed 6-2-21; 8:45 am]
BILLING CODE 3510-DS-P